InvAscent

Premium

General

03 April, 2023

InvAscent scores another exit from second fund

Healthcare-focused private equity firm InvAscent, which recently signed off from Hyderabad-based dermatology chain Oliva Skin and Hair Clinic via a ......

Premium

Healthcare

03 March, 2023

Exclusive: Three PE firms in race to pick up stake in NU Hospitals

At least three private equity firms have emerged as serious contenders to invest in NU Hospitals Pvt. Ltd, a south ......

Premium

Finance

23 September, 2022

Sterile injectables manufacturer Maiva in talks to raise fresh capital

Maiva Pharma Pvt. Ltd is in talks with private equity investors, including buyout funds, to raise $60-70 million (₹485 crore- ......

Premium

Healthcare

31 August, 2022

La Renon Healthcare eyeing IPO in 3-5 years after revenue doubles

La Renon Healthcare Pvt. Ltd aims to launch its initial public offering (IPO) in the next three to five years ......

Premium

Healthcare

08 August, 2022

Kedaara emerges frontrunner for majority stake in derma clinic chain

Homegrown private equity fund Kedaara Capital has emerged as the frontrunner to invest Rs 350 crore ($44 million) for a ......

Premium

Healthcare

13 July, 2022

Kedaara Capital frontrunner for significant minority stake in IVF chain

Homegrown private equity fund Kedaara Capital has emerged as frontrunner for a significant minority stake in IVF chain, Oasis Centre ......

Premium

Healthcare

02 June, 2022

Healthcare equipment maker Accumax raises $68 mn from Creador, InvAscent

Ahmedabad-based healthcare equipment manufacturer Accumax Lab Devices Pvt. Ltd has raised its first private equity funding of $68 million (around ......

Premium

Healthcare

24 March, 2022

IVF firm Oasis hires banker for fresh fundraise, InvAscent to exit

Oasis Centre for Reproductive Medicine, which runs a chain of in-vitro fertilization (IVF) centres, has hired investment bank o3 Capital ......

Premium

Healthcare

13 December, 2021

InvAscent exits Synergia life Sciences with over 11-fold returns after sale to Novozymes

Healthcare-focussed private equity (PE) firm InvAscent has exited Synergia Life Sciences Pvt Ltd, with over 11-fold returns after the vitamins ......

Premium

Healthcare

17 October, 2021

PE firms shift focus from traditional healthcare to healthtech investments post Covid

Private equity (PE) firms that were in favour of investing only in traditional healthcare companies are now warming up to ......